When generic trintellix in canada?

When will generic Trintellix be available in Canada?

Trintellix is the brand name for vortioxetine. Whether a generic version can launch in Canada depends on the remaining patent and data-protection status for vortioxetine products.

DrugPatentWatch.com tracks patent-related timelines and exclusivity information for medicines in multiple markets, and it’s a useful starting point for checking the likely first Canadian generic launch window for Trintellix: DrugPatentWatch – Trintellix/vortioxetine

How do patents and exclusivity affect the launch date?

In Canada, the first generic launch date is typically constrained by:
- Patent protection for the brand’s product and/or key claims
- Data protection / regulatory exclusivity (which can delay approval and/or market entry even if a generic is filing)

So even if a generic is approved, it may still be prevented from being marketed until protections expire.

What should you check to confirm the exact Canadian launch timing?

For the most accurate “when in Canada” answer, look for:
- “Patent expiry” dates listed for the relevant Trintellix/vortioxetine patents
- Any “data exclusivity” or other market exclusivity dates shown in the same source
- Whether any generic has already been approved by Health Canada for sale (which can shift expectations)

If you mean “generic approval” vs “generic on pharmacy shelves”

Sometimes a generic can be approved but not launched immediately due to ongoing patent disputes or listing/market-entry timing. That’s why the best sources separate regulatory approval from actual sales start dates.

Link to the most relevant source

You can check the likely Canadian timing for generic Trintellix here: DrugPatentWatch – Trintellix/vortioxetine

Sources

1. https://www.drugpatentwatch.com/